These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 2442411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.
    Nara PL, Robey WG, Gonda MA, Carter SG, Fischinger PJ.
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3797-801. PubMed ID: 3473484
    [Abstract] [Full Text] [Related]

  • 4. Immunodominant B-cell clones responsive to an HIV-1 neutralization and cell fusion inhibition epitope in chimpanzee-to-chimpanzee passages of HTLV-IIIB and LAV-1.
    Goudsmit J, Bakker M, Smit L.
    Res Virol; 1989 Jun; 140(5):405-18. PubMed ID: 2479965
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.
    Nara PL, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliher J, Gallo RC, Fischinger PJ, Goudsmit J.
    J Virol; 1990 Aug; 64(8):3779-91. PubMed ID: 2370681
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.
    Matsushita S, Robert-Guroff M, Rusche J, Koito A, Hattori T, Hoshino H, Javaherian K, Takatsuki K, Putney S.
    J Virol; 1988 Jun; 62(6):2107-14. PubMed ID: 2452899
    [Abstract] [Full Text] [Related]

  • 8. Specificity of chimpanzee antibodies binding a strain-specific HIV-1 neutralization epitope of the external envelope.
    Goudsmit J, Bakker M, Smit L, Meloen RH.
    J Med Primatol; 1989 Jun; 18(3-4):357-62. PubMed ID: 2474656
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.
    Palker TJ, Matthews TJ, Langlois A, Tanner ME, Martin ME, Scearce RM, Kim JE, Berzofsky JA, Bolognesi DP, Haynes BF.
    J Immunol; 1989 May 15; 142(10):3612-9. PubMed ID: 2469721
    [Abstract] [Full Text] [Related]

  • 11. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.
    Palker TJ, Clark ME, Langlois AJ, Matthews TJ, Weinhold KJ, Randall RR, Bolognesi DP, Haynes BF.
    Proc Natl Acad Sci U S A; 1988 Mar 15; 85(6):1932-6. PubMed ID: 2450351
    [Abstract] [Full Text] [Related]

  • 12. Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.
    Nara PL, Robey WG, Pyle SW, Hatch WC, Dunlop NM, Bess JW, Kelliher JC, Arthur LO, Fischinger PJ.
    J Virol; 1988 Aug 15; 62(8):2622-8. PubMed ID: 3392769
    [Abstract] [Full Text] [Related]

  • 13. Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.
    Arthur LO, Pyle SW, Nara PL, Bess JW, Gonda MA, Kelliher JC, Gilden RV, Robey WG, Bolognesi DP, Gallo RC.
    Proc Natl Acad Sci U S A; 1987 Dec 15; 84(23):8583-7. PubMed ID: 3479807
    [Abstract] [Full Text] [Related]

  • 14. Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.
    Arthur LO, Bess JW, Waters DJ, Pyle SW, Kelliher JC, Nara PL, Krohn K, Robey WG, Langlois AJ, Gallo RC.
    J Virol; 1989 Dec 15; 63(12):5046-53. PubMed ID: 2555541
    [Abstract] [Full Text] [Related]

  • 15. Extrathecal and intrathecal IgG response to the AIDS virus LAV/HTLV-III in experimental infection of chimpanzees.
    Goudsmit J, Gibbs CJ, Asher DM, Gajdusek DC.
    Cancer Detect Prev Suppl; 1987 Dec 15; 1():509-14. PubMed ID: 3480064
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees.
    Goudsmit J, Thiriart C, Smit L, Bruck C, Gibbs CJ.
    Vaccine; 1988 Jun 15; 6(3):229-32. PubMed ID: 3166553
    [Abstract] [Full Text] [Related]

  • 18. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.
    Nara PL, Hatch WC, Dunlop NM, Robey WG, Arthur LO, Gonda MA, Fischinger PJ.
    AIDS Res Hum Retroviruses; 1987 Jun 15; 3(3):283-302. PubMed ID: 3481271
    [Abstract] [Full Text] [Related]

  • 19. Variable and conserved neutralization antigens of human immunodeficiency virus.
    Weiss RA, Clapham PR, Weber JN, Dalgleish AG, Lasky LA, Berman PW.
    Nature; 1987 Jun 15; 324(6097):572-5. PubMed ID: 2431324
    [Abstract] [Full Text] [Related]

  • 20. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus.
    Fultz PN, Srinivasan A, Greene CR, Butler D, Swenson RB, McClure HM.
    J Virol; 1987 Dec 15; 61(12):4026-9. PubMed ID: 2446009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.